Scientists around the world are trying to come up with universal coronavirus vaccines to combat the emergence of variants. But what are these vaccines and are they even possible?
Academic rigor, journalistic flair
Articles on HIV vaccine
Displaying all articles
The key to ending the HIV epidemic is a vaccine that will provide long-lasting protection and alleviate the need for prevention methods.
The discovery of a new strain of HIV gives scientists a better understanding of the virus.
Researchers around the world are working hard to find a vaccine that is safe and effective.
Until then we need to get effective, accessible treatment for all who need it, while deploying the many prevention tools at our disposal.
World AIDS Day is Dec. 1. With many advances in preventing and treating the disease, the disease has fallen from top of mind for many. An epidemiologist explains why that could be dangerous.
HIV self-testing is a potential strategy to overcome access to testing. However, there are emerging concerns on the lack of counselling, possible user error and accuracy of the kits.
To get an effective vaccine for HIV/AIDS, scientists need to understand exactly how the virus works and immune system responds to it. African scientists have come one step closer.
A South African child, who has been in HIV remission for nearly nine years, could help researchers understand how to make remission possible for millions of other HIV positive people.
Researchers are learning how HIV hides from the immune system to develop a new generation of vaccines for seemingly unrelated diseases, like the flu.
For the next five years South Africa will be leading one of the latest large-scale trials for a vaccine for HIV.
A new animal study has shown injections of antibodies might protect against HIV infection, albeit for only a limited time.
Two major clinical trials will be conducted in South Africa in 2016 to test ways of preventing new HIV infections.
HIV has infected over seventy million people but only one of them has been cured: Timothy Ray Brown. An HIV-positive resident of Berlin, Germany, Brown developed relapsed leukemia in 2006. To treat the…
Three decades since the onset of the infection in a global population, HIV care and treatment is looking very different. Given the difficulties involved, it is remarkable that having developed good treatments…
Top contributors
-
Professor of medicine and deputy director of the Desmond Tutu HIV Centre at the Institute of Infectious Disease and Molecular Medicine, University of Cape Town
-
Professor, Biomedicine Discovery Institute, Monash University
-
Research Professor, Perinatal HIV Research Unit and President, South African Medical Research Council
-
Associate Professor, University of Nottingham
-
Director, The Peter Doherty Institute for Infection and Immunity, The University of Melbourne and Royal Melbourne Hospital and Consultant Physician, Department of Infectious Diseases, Alfred Hospital and Monash University, The Peter Doherty Institute for Infection and Immunity
-
Professor of Medicine, Dartmouth College
-
Medical Scientist at the National Institute for Communicable Diseases; Research Associate at CAPRISA; Research Professor in the School of Pathology, University of the Witwatersrand
-
Research Professor and DST/NRF SARChI Chair of Virus-Host Dynamics, National Institute for Communicable Diseases, CAPRISA Research Associate, University of the Witwatersrand
-
Medical Scientist, National Institute for Communicable Diseases
-
Medical Scientist, National Institute for Communicable Diseases
-
Associate Professor and Deputy Director, Centre for Virus Research, The Westmead Institute for Medical Research
-
Adjunct Associate Professor of Epidemiology, Columbia University
-
PhD candidate, Ghent University
-
Head: Cell Biology, Centre for HIV and STIs, National Institute for Communicable Diseases
-
Programme Director for the Sub-Saharan African Network for TB/HIV Research Excellence (SANTHE), University of KwaZulu-Natal
